发布需求
请登录 注册
Tocilizumab
  • HY-P9917
  • 皓元医药
  • 上海市
  • 一周内
  • 5mg
  • 5700
  • 2022-07-23 11:37:26

上海皓元生物医药科技有限公司

一键申请试用
咨询
加入意向单
联系方式
  • CAS号
  • 375823-41-9

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。

Tocilizumab

产品活性:Tocilizumab (Anti-Human IL6R, Humanized Antibody) 是一种抗人白细胞介素-6 受体 (IL-6R) 的中和抗体,可阻止 IL-6 与 IL-6R 的结合,从而抑制经典和反式信号。Tocilizumab 可用于类风湿性关节炎的相关研究。Tocilizumab 在重症 COVID-19 冠状病毒病方面的研究效果显著。

研究领域:Immunology/Inflammation

作用靶点:Interleukin Related

In Vitro: Tocilizumab (Anti-Human IL6R, Humanized Antibody) (1-100 ng/mL; 24 hours, 48 hours) inhibits the cell proliferation (growth rate) in a dose-dependent manner, growth rate by HACM is reduced almost completely by 100 ng/mL tocilizumab.
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (0.001-10,000 μg/ml; 2 days) inhibits Ba/F3-gp130-IL-6R cell proliferation stimulated with hIL-6 with an IC50 of 13.5 ng/ml.
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (1 μM; 6 hours) reduces the phosphorylation of STAT3 in vitro consistent with in vivo SAS cells.
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (1-5 μM; 24 hours) significantly reduces VEGF mRNA expression in SAS cells with serum-free medium.

In Vivo: Tocilizumab (Anti-Human IL6R, Humanized Antibody) (intravenous injection; 1.0 mg/100 μL; twice a week, three weeks) decreases the volume of each metastatic focus in tocilizumab-injected mouse brains.
Tocilizumab (Anti-Human IL6R, Humanized Antibody) (intraperitoneal injection;100 μg/mL, every 48 hours; 20days) suppresses OSCC progression and suppresses Tumor Angiogenesis.

相关产品:Resatorvid  |  Disulfiram  |  Deucravacitinib  |  Apilimod  |  LMT-28  |  Hydrocortisone hemisuccinate  |  Muscone  |  Diacerein  |  Dupilumab  |  APY0201  |  Vidofludimus  |  SC144  |  Semapimod tetrahydrochloride  |  Madecassic acid  |  Neochlorogenic acid  |  RCGD423  |  Y-320  |  Mulberroside A  |  Ginsenoside Rc  |  Pectolinarin  |  Methylthiouracil  |  VGX-1027  |  AX-024  |  IL-17A antagonist 1  |  Ossirene  |  Secukinumab  |  AF12198  |  BRD6989

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物,我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物;
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
•   设有专业的实验中心和严格的质控、验证体系;
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
•   产品的生物活性多经各国客户实验验证;
•   Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
•   专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
•   与世界各大制药公司及知名科研机构建立了长期的合作。

1000+ Inhibitors&Agonists 作用于20多条经典信号通路
30+ Screening Libraries 疾病机制研究的高效工具
CCK8 Kit | Cell Counting Kit-8
FDA-Approved 药物筛选库
Inhibitor Cocktails 蛋白酶, 磷酸酶 & 去乙酰化酶
Top Publications Citing Use of MCE
MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持

发布需求

意向单

反馈

400-661-8020

扫码关注订阅号
返回顶部